Teleflex Is in Talks to Buy German Biotronik's Stent Unit.

Teleflex Inc. is in discussions to acquire German medical technology firm Biotronik SE & Co.'s vascular intervention unit for €500 million to €1 billion. The unit manufactures stents and balloon catheters to treat blocked blood vessels. Teleflex faced challenges in this area due to a recall of some balloon catheters earlier this year. Biotronik is working with Goldman Sachs Group Inc. on the potential divestment of the unit to help pay off debts incurred during recent expansions. [Extracted from the article]